Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
70.60
-1.82 (-2.51%)
At close: Dec 4, 2025
56.54%
Market Cap 11.91B
Revenue (ttm) 9.30B
Net Income (ttm) 1.26B
Shares Out 168.76M
EPS (ttm) 7.45
PE Ratio 9.48
Forward PE 9.30
Dividend 1.50 (2.12%)
Ex-Dividend Date Apr 22, 2025
Volume 630,400
Average Volume 346,317
Open 72.42
Previous Close 72.42
Day's Range 70.00 - 72.90
52-Week Range 43.50 - 83.99
Beta 0.53
RSI 40.23
Earnings Date Nov 13, 2025

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.

Financial Statements

News

There is no news available yet.